MaxWell Biosystems successfully cleared Venture Kick Stage 2 and received CHF 20,000. See Venture Kick news here >> Venture Kick finances start-ups at the early stage with a grant of up to CHF 130,000 and provides professional support of business experts.
MaxWell Biosystems presented MaxOne at MipTec 2016 in Basel. As one of the events during Basel Life Science Week, over 100 life science companies worldwide gathered at the MipTec International Life Science Exhibition. The MaxWell Biosystems booth was located in the Innovation Village next to other start-up companies. Dr. Michele Fiscella, VP Scientific Affairs, gave daily product presentations on the features and applications of the MaxOne technology.
MaxWell Biosystems exhibited MaxOne and its applications for Cardiac Safety Pharmacology at the 2016 Safety Pharmacology Society (SPS) / Japanese Safety Pharmacology Society (JSPS) / Canadian Society of Pharmacology and Therapeutics (CSPT) Joint Meeting in Vancouver, BC, Canada. The meeting, held from the 18th to 21st of September 2016, had over 568 attendees from around the world, with 253 abstracts presented and 51 exhibiting companies.
MaxWell Biosystems received the ETH spin-off label and joins the strong list of ETH spin-off companies. MaxWell Biosystems continues to be in close collaboration with Prof. Dr. Andreas Hierlemann and the Bio Engineering Laboratory, Department of Biosystems Science and Engineering in Basel.
We are delighted to announce the official registration of MaxWell Biosystems AG in Canton Basel-City, Switzerland. MaxWell Biosystems is now part of Basel’s booming life science and tech start-up community with its close vicinity to multinational biotech and pharmaceutical companies.